Skip to Main Content

Author Details

Kenneth Dickstein
University of Bergen
1971
467
89
PMIDPaper TitleJournal TitlePublished Year
36795286Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction.J Cardiovasc Transl Res2024
36196060Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.Eur J Heart Fail2023
37649316Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry.ESC Heart Fail2023
37940229Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.J Am Coll Cardiol2023
37678961Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.JACC Heart Fail2023
37973338Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.Lancet Glob Health2023
37076773What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II.Eur Heart J Qual Care Clin Outcomes2023
36974770Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.Eur J Heart Fail2023
36997667Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure.Clin Res Cardiol2023
37062869Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE.Eur J Heart Fail2023
36883593Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure.Cardiovasc Res2023
36546588Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.Diabetes Obes Metab2023
36635707Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease.Cardiovasc Diabetol2023
36597718Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome.Eur J Heart Fail2023
36148485Albuminuria as a marker of systemic congestion in patients with heart failure.Eur Heart J2023
34264317Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF.Cardiovasc Res2022
35383463Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes.J Am Heart Assoc2022
35649488Heart failure with normal LVEF in BIOSTAT-CHF.Int J Cardiol2022
35429091Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).Eur J Heart Fail2022
35426256Clinical implications of low estimated protein intake in patients with heart failure.J Cachexia Sarcopenia Muscle2022
35393622Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.Eur Heart J2022
35596935Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.Eur J Heart Fail2022
35596674Distinct pathophysiological pathways in women and men with heart failure.Eur J Heart Fail2022
35817031Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.Diabetes Care2022
35450842Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish Population.Turk Kardiyol Dern Ars2022
35388650Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction.ESC Heart Fail2022
35748048Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure.Eur J Heart Fail2022
35654526Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF.JACC Heart Fail2022
36017729Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.Eur Heart J2022
36088651Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence.ESC Heart Fail2022
36049813Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure.JACC Heart Fail2022
35131929Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure.Clin J Am Soc Nephrol2022
35064730Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.Eur J Heart Fail2022
34989084Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure.Eur J Heart Fail2022
35294624Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure.Clin Res Cardiol2022
35049355The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction.J Womens Health (Larchmt)2022
34816550Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study.Eur J Heart Fail2022
34516969A global perspective of racial differences and outcomes in patients presenting with acute heart failure.Am Heart J2022
34687289Pathophysiological pathways in patients with heart failure and atrial fibrillation.Cardiovasc Res2022
32167657Effects of exergaming on exercise capacity in patients with heart failure: results of an international multicentre randomized controlled trial.Eur J Heart Fail2021
33742751Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure.Eur J Heart Fail2021
33742549The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure.J Cachexia Sarcopenia Muscle2021
33651430Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.Eur J Heart Fail2021
33544835Withdrawn as duplicate: Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care.Europace2021
33621540Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.Am Heart J2021
33759308Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study).Eur J Heart Fail2021
33620418Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.Eur Heart J Acute Cardiovasc Care2021
33870728Impaired High-Density Lipoprotein Function in Patients With Heart Failure.J Am Heart Assoc2021
33839078Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.JACC Heart Fail2021
33728762Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.Eur J Heart Fail2021
  • 1 - 50 of 467

Recommended Authors

Veraprapas Kittipibul
Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 3
Mohammad Al-Ani
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
Adam D DeVore
Duke University School of Medicine, NC Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 19
Marat Fudim
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 16
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 4
Iwan C C van der Horst
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University
Career Start Year 2001
Number of shared co-authors 3
Tobias Breidthardt
University Hospital Basel, University of Basel
Career Start Year 2001
Number of shared co-authors 6
Benjamin M Scirica
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 11
Lee R Goldberg
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 9
Juan M Aranda
University of Florida
Career Start Year 1997
Number of shared co-authors 1
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 7
Naveen L Pereira
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 6
Frederick A Masoudi
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 18
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 11
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 8
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
Peter A McCullough
Truth for Health Foundation
Career Start Year 1992
Number of shared co-authors 20
Rekha Garg
University of Florida
Career Start Year 1991
Number of shared co-authors 0
Vinay Thohan
Mission Hospital
Career Start Year 1989
Number of shared co-authors 12
Paul A Heidenreich
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 20
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 11
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 17
Mariell Jessup
University of Pennsylvania Perelman School of Medicine
Career Start Year 1987
Number of shared co-authors 25
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 1
Jalal K Ghali
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 18
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 2
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 5
Alan S Maisel
University of California
Career Start Year 1976
Number of shared co-authors 31
Ezra A Amsterdam
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 17
Kurt Boman
Research Unit, Skelleftea County Hospital
Career Start Year 1949
Number of shared co-authors 4

Collaborators

Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 98
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 88
Nilesh J Samani
Co-authored papers 58
William T Abraham
The Ohio State University
Co-authored papers 32
Carolyn S P Lam
Duke-NUS Medical School
Co-authored papers 28
Pim van der Harst
Co-authored papers 16
Akshay S Desai
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 16
Ulf Dahlstr??m
Linkoping University
Co-authored papers 16
Milton Packer
Co-authored papers 15
Markku S Nieminen
Co-authored papers 15
Georg Ertl
University Hospital Wurzburg
Co-authored papers 14
Rudolf A de Boer
Co-authored papers 14
Mathieu Ghadanfar
Novartis Pharma AG
Co-authored papers 14
Christiane E Angermann
University and University Hospital Wurzburg
Co-authored papers 13
Mahmoud Hassanein
Alexandria University
Co-authored papers 13
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 13
Achim Obergfell
Novartis Pharma
Co-authored papers 13
Alexandre Mebazaa
INSERM UMR-S , Universite de Paris Cite
Co-authored papers 12
Michel Komajda
Saint Joseph Hospital, Paris-Sorbonne University
Co-authored papers 12
Anja Schweizer
Novartis Pharma AG
Co-authored papers 11
Sergio V Perrone
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Co-authored papers 10
Elliott M Antman
Co-authored papers 9
Adrian F Hernandez
Duke University Medical Center
Co-authored papers 9
Robert M Califf
From the National Institutes of Health
Co-authored papers 8
Barbara Riegel
University of Pennsylvania
Co-authored papers 8
Rick A Nishimura
Mayo Clinic
Co-authored papers 8
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Co-authored papers 8
Burkert Pieske
Charite University Medicine, Berlin Institute of Health (BIH)
Co-authored papers 7
Barry M Massie
University of California at San Francisco
Co-authored papers 7
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 5
Release 1.2